Enjoy complimentary customisation on priority with our Enterprise License!
The global prefilled syringe market is projected to reach a value of USD 3.51 billion with an accelerated CAGR of 8.93% between 2022 and 2027. The adoption of PFS for insulin delivery is anticipated to be in demand, fueled by the rising prevalence of diabetes. The market is experiencing significant growth with a focus on trends and analysis. Market research and growth initiatives contribute to comprehensive market analysis and reports. The market forecasting trends in growth remain a priority, positioning prefilled syringe manufacturers to adapt and meet the evolving needs of the healthcare industry effectively.
To learn more about this report, Download Report Sample
The transition from glass pre-filled syringes to plastic pre-filled syringes is projected to drive the market's advancement. The market is witnessing a substantial rise driven by the growing presence of these convenient and user-friendly medical devices. Plastic PFS or polymer syringes currently hold approximately 40% of the market share. They are growing in popularity as a result of the developments of sophisticated polymer materials that are biocompatible with the other syringe components, like polypropylene and crystal-clear polymer. Since material glass makes up the vast majority on the market under consideration.
The persistent emphasis on improving safety aims to mitigate drug waste while broadening treatment options and therapies available. In addition, the pharmaceutical industry is moving towards plastic and single-use syringes, which safeguard needle stick injuries and needle system prevent their reuse disposable systems. Their advantages, including ease of use, reduced risk of anaphylaxis, and potential for self-administration, have significantly influenced their adoption in healthcare facilities settings like hospitals.
For instance, Autoinjectors and wearable injectors are innovative devices used to administer medications, biologics, vaccines, and small molecules to patients. They offer a user-friendly and convenient method for consumers to deliver precise doses. Autoinjectors are devices that enable easy and controlled injections of a predetermined dosage of medication. Whereas, wearable injectors are a type of advanced drug delivery system that patients can wear on their skin. Both autoinjectors and wearable injectors can be programmed or designed to deliver customizable dosages, tailored to the specific needs of patients. Additionally, both autoinjectors and wearable injectors are innovative drug delivery devices that not only enhance patient convenience but also contribute to improved treatment adherence, better disease management, and enhanced patient outcomes.
The cost-effectiveness of these injection compared to traditional vials, along with their compliance with government regulations and approvals, further accentuates their market growth. Emphasis on incorporating safety devices offers patients secure and reliable options for self-administration, aligning with healthcare facilities providers' plans to enhance patient care. The prevalence of needlestick injuries underscores the need for safety measures within the manufacturing and utilization. Additionally, the Packaging of parenteral and aseptic product packaging is costly. Continuous developments in this sector, coupled with the rising incidence of chronic diseases and the need for safe and efficient drug delivery methods, continue to drive the demand making them a prominent component in modern drug administration practices. Such excellence contributes to the evolution of healthcare ways and projections.
The Glass Pre-filled Syringe market segment will Dominate the Market
The Glass prefilled syringe segment was the largest and was valued at USD 3.60 billion in 2017. The segment is anticipated to significantly boost the market in focus because they are easier to regulate, more widely accepted by end users, and have a greater selection of medications than plastic. They are disposable needle systems containing pre-packaged pharmaceuticals or biologicals for injectables that are ready to use.
The focus on diabetes care addressing conditions like type 1 diabetes has spurred advancements in treatments and insulin delivery methods. The choice of route of administration within the segment has gained prominence due to its effectiveness and ease of use, contributing to diverse product portfolios. It is considered the gold standard, as the material has been popular in the pharmaceutical industry for decades compared with plastic.
For more details on other segments, Download Sample Report
Disposable syringes are discarded immediately after use or exposure to an unsterile environment. Single-use syringes are pivotal components within the medical field, specifically designed for one-time utilization. The availability for a wide range of therapies, including treatments for cancer and biosimilars, contributes to their growing benefits in the healthcare sector. Moreover, their cost-effectiveness compared to traditional vials is fostering their adoption, making them a preferred choice for drug delivery.
For Instance, by eliminating the possibility of reuse, single-use effectively decreases the chances of infections or the transmission of diseases from one individual to another. Healthcare practitioners and medical professionals widely recognize and adhere to the principle of single-use due to their sterile and disposable nature. The disposable attribute of single-use underscores their importance in maintaining patient safety and preventing the spread of infections or diseases. The disposable is attribute of single-use syringes underscores their importance in maintaining patient safety and preventing the spread of infections or diseases. Healthcare practitioners and medical professionals widely recognize and adhere to the principle of single-use due to their sterile and disposable nature.
North America Holds a Prominent Position in the Market
North America dominates the market with a revenue share of around 36%. The are becoming more and more popular in this region due to the rising prevalence of chronic illnesses like diabetes and infectious diseases that can be prevented by vaccination. This market's expansion is further propelled by technological advancements in syringe design and the increasing demand for these devices in various medical settings, including hospitals and clinics, across regions like Japan, Italy, and others. These play a crucial role in delivering medications for various conditions like cancer, and rheumatoid arthritis, and biosimilars, particularly in regions such as the United States, New Zealand, Italy, South Korea, and Spain
In the market, the Asia-Pacific region stands as a focal point for product launches and market expansion initiatives due to rising healthcare facilities needs and an increasing focus on lifestyle diseases. Key players like Terumo Corporation play pivotal roles in introducing innovative safety and self-injection devices, catering to the consumer's demand for user-friendly medical tools. Regions such as Switzerland, Israel, and industry giants like Nipro Corporation drive the narrative of advancements in this sector, painting a scenario of innovation and progress in safety across global healthcare operations.
Regional Analysis, Global, 2017-2027
To understand geographic trends Download Report Sample
The companies are pivotal in shaping market trends and analysis. Their strategies align with comprehensive market growth analysis and forecasting. Adapting to evolving market trends, these vendors contribute to both short-term forecasts and long-term market growth, ensuring they remain key players in meeting the growing demand for efficient and user-friendly healthcare solutions.
Companies like Catalent Inc. and Elcam Medical are integral players contributing to the evolution of safety features in syringe design and manufacturing processes, especially focusing on materials like glass to ensure product integrity. Furthermost market players like Toppac Hungary's NewCo and Stevanato Group are pioneering advancements in the healthcare industry, marking significant milestones.
The market growth and trends report also includes detailed analyses of the competitive landscape and collaboration of the market and information about 15 market companies, including:
Catalent Inc., Fresenius SE and Co. KGaA, Gerresheimer AG, Haselmeier GmbH, Nipro Corp., Novartis AG, Owen Mumford Ltd., Recipharm AB, SCHOTT AG, SHL Medical AG, SERINOVA, Terumo Corp., Vetter Pharma Fertigung GmbH and Co. KG, Viatris Inc., and West Pharmaceutical Services Inc.
The market growth and forecasting report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 - 2021.
Pre-filled Syringes Market Scope |
|
Report Coverage |
Details |
Page number |
163 |
Base year |
2022 |
Historic period |
2017 - 2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 8.93% |
Market growth 2023-2027 |
USD 3.51 billion |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
7.77 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 36% |
Key countries |
US, Canada, Germany, UK, and China |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Ajinomoto Bio Pharma Services, ApiJect Systems Corp., AptarGroup Inc., Baxter International Inc., Becton Dickinson and Co., Catalent Inc., Fresenius SE and Co. KGaA, Gerresheimer AG, Haselmeier GmbH, Nipro Corp., Novartis AG, Owen Mumford Ltd., Recipharm AB, SCHOTT AG, SHL Medical AG, STERINOVA, Terumo Corp., Vetter Pharma Fertigung GmbH and Co. KG, Viatris Inc., and West Pharmaceutical Services Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements.
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.